<DOC>
	<DOCNO>NCT00971269</DOCNO>
	<brief_summary>The study open , prospective , single-site study 16 patient suffer fecal incontinence include . Change fecal incontinence episode intersphincteric injection NASHA/Dx gel 4x2 ml retreatment 4x2 ml 4 week measure .</brief_summary>
	<brief_title>Pilot Study NASHA/Dx Gel Fecal Incontinence</brief_title>
	<detailed_description />
	<mesh_term>Fecal Incontinence</mesh_term>
	<criteria>1 . Fecal incontinence least 2 episodes/week 2 . Symptom duration least one year 3 . Failed attempt conservative therapy 4 . Age 1880 5 . Written inform consent 6 . Available followup 7 . Fully compliant protocol 1 . Active inflammatory bowel disease 2 . Total external sphincter defect ultrasound clinical examination 3 . Bleeding diathesis anticoagulant therapy 4 . Rectal prolapse intussusception 5 . Present anal sepsis 6 . Anorectal implant 7 . Recent anorectal surgery ( within 6 month ) 8 . Rectal anastomosis 9 . Pregnancy , postpartum ( one year ) breast feeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2009</verification_date>
</DOC>